MSL
LRND icon

Mackay Shields LLC’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

Mackay Shields LLC’s Portfolio LRND Stock Details LRND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-190,000
Closed -$4.78M – 509
2022
Q1 		$4.78M Buy
+190,000
New +$4.63M 0.04% 364

Other funds holding LRND

NYLIM
New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

Mackay Shields LLC's LRND Position: Q2 2022 in Review

Mackay Shields LLC sold out of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) in Q2 2022, closing a stake of 190,000 shares — an estimated $4.78M sold.

Mackay Shields LLC first reported a position in LRND in Q1 2022 and held it in 1 quarter. The position peaked at $4.78M in Q1 2022. 1 fund tracked by Wall St. Rank holds LRND as of Q2 2022.

  • Mackay Shields LLC reported no remaining New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 190,000 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2022, an estimated $4.78M.
  • Mackay Shields LLC first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q1 2022 and held it in 1 quarter.
  • Mackay Shields LLC's New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position peaked at $4.78M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.